Journal · Scientific
Seasonal Hair Loss in Autumn: Causes, PRP, and Mesotherapy

With the onset of autumn, dropping temperatures, and shortening daylight hours, many individuals observe a dramatic accumulation of loose strands on their pillows, hairbrushes, and shower drains. While this sudden shedding frequently triggers alarm and anxieties regarding irreversible balding, it is predominantly a physiological mammalian adaptation. Human hair follicles are intrinsically attuned to seasonal bioclimatic rhythms, making seasonal hair loss autumn a recognized clinical phenomenon that reaches its peak between October and November.
However, distinguishing whether increased shedding represents a self-limiting biological cycle or unmasks an underlying genetic vulnerability (androgenetic alopecia) or nutritional deficiency is critical. Unaddressed telogen effluvium can accelerate follicular miniaturization and cause progressive reduction in overall scalp density. In this clinical guide, grounded in peer-reviewed trichological literature, we examine the cellular mechanisms of autumn shedding, our clinic's regenerative protocols using hair mesotherapy, PRP, and exosomes, and their objective clinical parameters.
Why does hair shedding spike in autumn: Seasonal cycles and telogen effluvium
Hair follicles progress continuously through three distinct life phases: anagen (growth), catagen (involution), and telogen (quiescence and shedding). The seasonal shift that destabilizes this balance is governed by well-documented physiological triggers:
- The delayed biological impact of summer ultraviolet exposure: Intense ultraviolet (UV) radiation sustained during summer months induces phototoxic oxidative stress within scalp tissue; follicles enter premature catagen to preserve cellular integrity, resulting in noticeable shedding 2 to 3 months later during autumn.
- Melatonin and circadian photoperiod alterations: Decreasing daylight duration in autumn alters endocrine photoperiodic signals; in a landmark study published by Kunz and colleagues in Dermatology (DOI: 10.1159/000216832), follicular shedding was proven to surge synchronously among healthy women during autumn months.
- Post-vacation stress and cutaneous vasoconstriction: Heightened occupational demands combined with cold-induced microvascular constriction in the galea capitis diminish micro-nutrient perfusion to active hair bulbs, exacerbating shedding.
Seasonal shedding vs. genetic alopecia: How are they differentiated clinically?
When evaluating patients presenting with acute hair shedding, our primary clinical objective is establishing an accurate trichoscopic diagnosis:
- Diffuse shedding distribution: Seasonal telogen effluvium is characterized by uniform, diffuse loss across the entire scalp; hairs shed with their characteristic white keratinous bulb intact, without focal recession of the frontal hairline or localized vertex thinning.
- The standardized hair pull test: During clinical consultation, an experienced physician gently exerts traction on a bundle of 50 to 60 hairs; extracting more than 6 telogen hairs confirms active shedding.
- Digital trichoscopy evaluation: Magnified epiluminescence microscopy visualizes follicular unit density and hair shaft diameter diversity; the absence of shaft diameter variation (anisotrichosis) confirms a purely seasonal telogen shift, whereas significant miniaturization indicates concurrent androgenetic alopecia.
Evidence-based clinical protocols: Hair Mesotherapy, PRP, and Exosomes
To halt seasonal shedding rapidly and transition dormant follicles back into active anagen proliferation, our clinic implements multi-modal regenerative therapies:
- Biological hair mesotherapy: Micro-injections delivering pharmaceutical-grade B-complex vitamins, biotin, biomimetic peptides, zinc, and uncrosslinked hyaluronic acid directly into the follicular bed; this nourishes the dermal papilla, accelerates keratin synthesis, and enhances local capillary circulation.
- Platelet-Rich Plasma (PRP) therapy: Autologous thrombocyte concentrate derived via certified centrifugation releases high concentrations of VEGF (vascular endothelial growth factor) and PDGF; as demonstrated by Gentile and colleagues in Stem Cells Transl Med (DOI: 10.5966/sctm.2015-0107), autologous PRP significantly boosts follicular density and increases the anagen-to-telogen ratio.
- Cellular exosome therapy: Stem cell-derived nano-vesicles loaded with growth factors, signaling proteins, and regulatory microRNAs deliver potent cellular revitalization directly to fatigued follicles, stimulating robust biological signaling in refractory shedding.
What hair loss therapies cannot accomplish: Objective clinical boundaries
Maintaining rigorous medical ethics requires delineating the biological limits of non-surgical trichological treatments:
- Cannot revive atrophied, fibrotic, or absent follicles: Once follicular ostia have vanished and scar tissue replaces the dermal papilla, non-surgical injections cannot generate de novo follicles; in areas of established balding, surgical hair restoration represents the only viable corrective modality.
- Therapeutic timelines are bounded by biological hair growth kinetics: Scalp hair elongates at an average rate of 1 to 1.5 cm per month; while mesotherapy and PRP arrest acute shedding within 2 to 4 weeks, measurable improvements in shaft caliper and overall volume require 3 to 6 months.
- Topical shampoos alone cannot resolve medical shedding: Cleansing formulations remain on the scalp for mere minutes and cannot penetrate the deep subcutaneous follicular bulb; anti-loss shampoos serve solely as supportive hygiene measures rather than primary medical treatments.
Frequently Asked Questions (FAQ)
How many hairs shed per day is considered normal during autumn?
In a healthy adult, losing 50 to 100 hairs daily is physiologically normal. During the autumn seasonal peak, this count may temporarily elevate to 150 to 200 hairs per day. However, if elevated shedding persists beyond 6 to 8 weeks, formal clinical trichological evaluation is essential.
How many sessions of hair mesotherapy and PRP are recommended?
To curb seasonal shedding and fortify hair shafts, the clinical gold standard entails 3 to 4 sessions of mesotherapy spaced 2 weeks apart, combined with 2 to 3 sessions of PRP performed at monthly intervals.
Will the hair that shed during autumn grow back?
Yes; in seasonal telogen effluvium, the hair follicle remains biologically viable and merely enters a temporary resting phase. As long as the follicle is preserved, new growth initiates within 2 to 3 months; mesotherapy and PRP significantly accelerate this regrowth while improving shaft diameter.
Can medical treatments replace surgical hair transplantation?
No; hair mesotherapy, PRP, and exosomes are preventative and revitalizing modalities designed to rescue existing, miniaturized follicles. In regions where follicles have undergone complete atrophy, surgical transplantation is the sole permanent solution.
Is the procedure painful?
Topical cold-air analgesia and specialized micro-fine mesotherapy needles minimize procedural discomfort; the treatment is completed comfortably within 15 to 20 minutes without significant pain or social downtime.
Consultation and Clinical Assessment
Identifying the root cause of hair shedding begins with a comprehensive medical history and targeted blood testing, including serum ferritin, vitamin B12, vitamin D, and thyroid profiles. To intercept seasonal shedding before it compromises permanent follicular density, contact Dr. Canan Demir clinic to schedule your comprehensive trichological consultation.
Medical Disclaimer
The trichological data and clinical explanations provided in this article are intended solely for educational and information only purposes. They do not constitute formal medical diagnosis, clinical prescriptions, or guarantees of follicular regrowth. Always consult a licensed medical physician for personalized diagnostic evaluation before initiating hair loss therapies.
References
1. Kunz M, Seifert B, Trüeb RM. Seasonality of hair shedding in healthy women complaining of hair loss. Dermatology. 2009;219(2):105-110. DOI: 10.1159/000216832.
2. Gentile P, Garcovich S, Bielli A, Scioli MG, Orlandi A, Cervelli V. The effect of platelet-rich plasma in hair regrowth: a randomized placebo-controlled trial. Stem Cells Transl Med. 2015;4(11):1317-1323. DOI: 10.5966/sctm.2015-0107.
3. Headington JT. Telogen effluvium: new concepts and review. Arch Dermatol. 1993;129(3):356-363. DOI: 10.1001/archderm.1993.01680240096017.
4. Goren A, Shapiro J, Roberts J, et al. Clinical utility of telogen shedding patterns in diagnosing androgenetic alopecia vs telogen effluvium. J Cosmet Dermatol. 2017;16(4):534-537. DOI: 10.1111/jocd.12356.
5. Rodrigues BL, Montalvão SALR, Cancela RBB, et al. Treatment of male pattern alopecia with platelet-rich plasma: a double-blind, randomized, placebo-controlled study. Dermatol Surg. 2020;46(6):785-794. DOI: 10.1097/DSS.0000000000002248.